Skip to main content

GE Healthcare, Harvard Lab to Develop New Software for IN Cell System

NEW YORK, Aug. 8 (GenomeWeb News) - GE Healthcare has given an IN Cell 1000 imaging system to  Harvard University's Center for Neurodegeneration and Repair, and said it and the university will  develop new software applications for the platform, the companies said today.


The IN Cell systems will primarily be used by HCNR researchers investigating neurodegenerative diseases and the central nervous system using a software package that includes fully validated analysis routines for rapid analysis of a range of biological processes, GE and HCNR said.


HCNR has also been given access to the IN Cell Toolbox to accommodate applications of the system where pre-developed analysis routes are not appropriate.


Additional terms of the partnership were not disclosed. More detail about the collaboration is available from Cell-Based Assay News, a GenomeWeb News sister publication, here.

The Scan

Rise of B.1.617.2 in the UK

According to the Guardian, UK officials expect the B.1.617.2 variant to soon be the dominant version of SARS-CoV-2 there.

Anne Schuchat to Retire

Anne Schuchat is retiring after more than 30 years at the US Centers for Disease Control and Prevention, Politico reports.

US to Share More Vaccines

CNN reports that the US will share 20 million doses of the Moderna, Pfizer, and Johnson & Johnson SARS-CoV-2 vaccines with other countries.

PNAS Papers on Gene Therapy Platform, Aspergillus Metabolome, Undernutrition Model Microbiome

In PNAS this week: approach to deliver protein-based treatments to cells, pan-secondary metabolome of Aspergillus, and more.